Shen G, Zhou H, Jia Z, Deng H
Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Br J Radiol. 2015 Aug;88(1052):20150063. doi: 10.1259/bjr.20150063. Epub 2015 May 29.
In recent years, diffusion-weighted (DW) MRI has emerged as a new technique for detecting the pelvic lymph metastases in patients with cervical cancer. The aim of this meta-analysis was to assess the diagnostic value of DW imaging (DWI) for benign/malignant discrimination of pelvic lymph nodes (LNs). Studies about DWI for the detection of metastatic LNs were searched in the PubMed, EMBASE, Web of Science, EBSCO, the Cochrane Library and three Chinese databases. Based on the extracted data, we determined pooled sensitivities, specificities and diagnostic odds ratios (DORs) across studies, calculated positive and negative likelihood ratios (LRs) and constructed summary receiver operating characteristic curves with area under the curve (AUC) and Q* obtained. We also analysed the heterogeneity between studies based on subgroup analysis, threshold effect and publication bias. In total, 15 studies involving 1021 patients met the inclusion criteria. The pooled sensitivity, specificity and DOR of DWI were 0.86 [95% confidence interval (CI), 0.84-0.89], 0.84 (95% CI, 0.83-0.86) and 47.21 (95% CI, 25.67-86.81), respectively. LR syntheses yielded overall positive LR of 6.55 (95% CI, 4.77-9.01) and negative LR of 0.17 (95% CI, 0.12-0.23). The AUC and Q* index were 0.9384 and 0.8754, respectively. The heterogeneity was relatively high between studies; however, there was no evidence for threshold effect and publication bias. DWI is beneficial in the pelvic nodal assessment in patients with cervical cancer. Large-scale, high-quality trials with standard protocols are required to evaluate its clinical value for discrimination of metastatic from non-metastatic pelvic LNs in patients with cervical cancer. Advances in knowledge include providing evidence to assess the role of DWI in nodal staging of cervical cancer.
近年来,扩散加权磁共振成像(DW MRI)已成为检测宫颈癌患者盆腔淋巴结转移的一项新技术。本荟萃分析的目的是评估扩散加权成像(DWI)对盆腔淋巴结(LNs)良恶性鉴别的诊断价值。在PubMed、EMBASE、科学网、EBSCO、考克兰图书馆以及三个中文数据库中检索有关DWI检测转移性淋巴结的研究。基于提取的数据,我们确定了各研究的合并敏感度、特异度和诊断比值比(DOR),计算了阳性和阴性似然比(LR),并构建了带有曲线下面积(AUC)和Q的汇总受试者工作特征曲线。我们还基于亚组分析、阈值效应和发表偏倚分析了各研究之间的异质性。共有15项涉及1021例患者的研究符合纳入标准。DWI的合并敏感度、特异度和DOR分别为0.86[95%置信区间(CI),0.84 - 0.89]、0.84(95% CI,0.83 - 0.86)和47.21(95% CI,25.67 - 86.81)。LR综合分析得出总体阳性LR为6.55(95% CI,4.77 - 9.01),阴性LR为0.17(95% CI,0.12 - 0.23)。AUC和Q指数分别为0.9384和0.8754。各研究之间的异质性相对较高;然而,没有证据表明存在阈值效应和发表偏倚。DWI有助于宫颈癌患者的盆腔淋巴结评估。需要开展采用标准方案的大规模、高质量试验,以评估其在鉴别宫颈癌患者盆腔转移性与非转移性淋巴结方面的临床价值。知识进展包括为评估DWI在宫颈癌淋巴结分期中的作用提供证据。